SCHEMBL4551617

SCHEMBL4551617

CC(=O)Nc1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.67
ALDH1A1 P00352 4/20 0.67
HPGD P15428 4/20 0.67
KMT2A Q03164 4/20 0.67
GLA P06280 3/20 0.67
GAA P10253 3/20 0.67
MEN1 O00255 3/20 0.61
ALOX5 P09917 1/20 0.58
RAF1 P04049 4/20 0.58
MAPK13 O15264 5/20 0.57
MAPK12 P53778 5/20 0.57
MAPK11 Q15759 5/20 0.57
MAPK14 Q16539 5/20 0.57
MAPT P10636 3/20 0.57
GCGR P47871 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C19 P33261 1/20 0.57
GFER P55789 1/20 0.57
NOX1 Q9Y5S8 1/20 0.57
TP53 P04637 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29622965 0.94 KDM4E (0.58) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL6466096 0.94 RAF1 (0.68) KDM4EALDH1A1HPGDKMT2AGLA
Hydrochloric Acid SCHEMBL29623104 0.93 KDM4E (0.57) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL13008480 0.87 KMT2A (0.62) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL14355066 0.87 RAF1 (0.62) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL20445311 0.86 ALDH1A1 (0.56) KDM4EALDH1A1HPGDKMT2AGLA
Hydrochloric Acid SCHEMBL23736198 0.85 ALDH1A1 (0.55) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL19868852 0.83 MAPK11 (0.70) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL13008486 0.81 KMT2A (0.54) KDM4EALDH1A1HPGDKMT2AGLA
SCHEMBL5074753 0.81 MAPK13 (0.83) KDM4EALDH1A1HPGDKMT2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof REDPOINT BIO CORPORATION 2007-11-08 US claimed
EP-2015638-A2 TRIARYL SUBSTITUTED IMIDAZOLE DERIVATIVES AND TASTE-INHIBITING USES THEREOF Redpoint Bio Corporation (US) 2009-01-21 EP disclosed
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof REDPOINT BIO CORPORATION 2007-11-08 US disclosed
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof REDPOINT BIO CORPORATION 2007-11-08 US disclosed
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof REDPOINT BIO CORPORATION 2007-11-08 US disclosed
WO-2007127479-A2 TRIARYL SUBSTITUTED IMIDAZOLE DERIVATIVES AND TASTE-INHIBITING USES THEREOF REDPOINT BIO CORPORATION (US) 2007-11-08 WO disclosed
WO-2007127479-A2 TRIARYL SUBSTITUTED IMIDAZOLE DERIVATIVES AND TASTE-INHIBITING USES THEREOF REDPOINT BIO CORPORATION (US) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof TAS1R3, TAS2R1, TAS1R1 KDM4E 3422/4885ALDH1A1 407/4885HPGD 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.